THE HART SURGERY — All Prescriptions & Medications — Page 11
Practice Code: K84001 | HENLEY-ON-THAMES, RG9 2DR
Showing results 501-550 of 565
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 13 | 64 | £256 | +113.4% ▲ | |
| 13 | 780 | £242 | +0.7% vs avg | |
| 13 | 3,220 | £507 | +11.3% ▲ | |
| Mebeverine hydrochloride compound preparations | 12 | 652 | £568 | +6.1% ▲ |
| Nizatidine | 12 | 720 | £1.6K | -65.1% ▼ |
| Balsalazide sodium | 12 | 2,016 | £449 | -19.4% ▼ |
| Glyceryl trinitrate | 12 | 360 | £449 | -9.7% ▼ |
| Ranolazine | 12 | 960 | £186 | -92.9% ▼ |
| Pentoxifylline | 12 | 1,620 | £332 | -4.2% ▼ |
| Glycopyrronium/formoterol | 12 | 12 | £371 | -52.6% ▼ |
| Temazepam | 12 | 310 | £275 | -79.0% ▼ |
| Rimegepant | 12 | 146 | £1.9K | +22.3% ▲ |
| Galantamine | 12 | 336 | £296 | -68.3% ▼ |
| Oxytetracycline | 12 | 1,512 | £501 | -53.5% ▼ |
| Clindamycin hydrochloride | 12 | 532 | £132 | +19.9% ▲ |
| Vardenafil | 12 | 76 | £62 | -14.1% ▼ |
| Tube feed 1.2 kcal/ml with fibre, higher protein (0914011) | 12 | 540.0K | £9.6K | +10.1% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 12 | 329.0K | £7.8K | +25.1% ▲ |
| Ketoprofen | 12 | 1,200 | £52 | -66.6% ▼ |
| Brinzolamide/brimonidine | 12 | 105 | £184 | -65.0% ▼ |
| Cocois | 12 | 940 | £157 | -12.6% ▼ |
| 12 | 29 | £174 | -66.4% ▼ | |
| Rabeprazole sodium | 11 | 588 | £58 | -78.7% ▼ |
| Prazosin hydrochloride | 11 | 3,696 | £159 | -34.7% ▼ |
| Valsartan with diuretic | 11 | 308 | £149 | -17.0% ▼ |
| Tinzaparin sodium | 11 | 347 | £2.7K | -25.7% ▼ |
| Ciclesonide | 11 | 15 | £391 | -25.3% ▼ |
| Citalopram hydrochloride | 11 | 225 | £155 | -31.5% ▼ |
| Almotriptan | 11 | 102 | £226 | -11.3% ▼ |
| Glucagon | 11 | 11 | £250 | -27.7% ▼ |
| Medroxyprogesterone acetate | 11 | 788 | £164 | -71.3% ▼ |
| Triptorelin | 11 | 11 | £2.3K | -47.8% ▼ |
| Benzalkonium chloride | 11 | 3,800 | £91 | -17.9% ▼ |
| Benzoyl peroxide | 11 | 540 | £67 | -21.9% ▼ |
| 11 | 406 | £63 | -95.0% ▼ | |
| 11 | 39 | £649 | +61.7% ▲ | |
| 11 | 210 | £63 | -50.7% ▼ | |
| 11 | 1,680 | £1.4K | -66.7% ▼ | |
| 11 | 1,620 | £573 | +56.7% ▲ | |
| 11 | 330 | £1.2K | -57.5% ▼ | |
| 11 | 330 | £1.2K | -21.4% ▼ | |
| 11 | 330 | £283 | +66.8% ▲ | |
| 11 | 330 | £1.9K | +26.0% ▲ | |
| Aclidinium bromide/formoterol | 10 | 10 | £309 | -71.6% ▼ |
| Opicapone | 10 | 300 | £590 | -47.8% ▼ |
| Levodopa/carbidopa/entacapone | 10 | 1,128 | £704 | -64.2% ▼ |
| Ivermectin | 10 | 73 | £944 | +2.5% ▲ |
| Biphasic insulin lispro | 10 | 100 | £620 | -76.7% ▼ |
| Testosterone undecanoate | 10 | 13 | £1.1K | -60.6% ▼ |
| Alfuzosin hydrochloride | 10 | 780 | £70 | -86.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.